Although
biopharmaceuticals offer significant profit margins and have been proven to be
effective in treating a myriad of diseases, they are generally associated with
high costs of development and complex manufacturing protocols; this is true for
antibody-based products as well. Presently, there are a number of companies
that claim to offer end-to-end solutions, ranging from antibody development to
commercial production. Further, prevalent trends suggest that sponsor companies
are likely to continue relying on contract service providers for various
aspects of antibody-based product development and manufacturing.
To order this 285+ page report, which features 100+ figures
and 110+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
The USD 17 billion (by 2030) financial opportunity
within the antibody contract manufacturing market has been analyzed across the
following segments:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
The Antibody Contract Manufacturing Market, 2020-2030 report features the
following companies, which we identified to be key players in this domain:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Competitive Analysis
6. Company Profiles
7. Case Study: Comparison of Small and Large
Molecules (Biologics) Drugs / Therapies
8. Benchmark Analysis
9. Partnerships
10. Recent Expansions
11. Capacity Analysis
12. Demand Analysis
13. Market Sizing and Opportunity Analysis
14. SWOT Analysis
15. Future of The Antibody CMO Market
16. Interview Transcripts
17. Appendix 1: List of Antibody Custom Manufacturers
18. Appendix 2: Tabulated Data
19. Appendix 3: List of Companies and
Organizations
To purchase a copy,
please visit https://www.rootsanalysis.com/reports/view_document/antibody-cmo-market/295.html
Contact Details
Gaurav Chaudhary
+1
(415) 800 3415
gaurav.chaudhary@rootsanalysis.com
